Medications for Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL

Other names: Fredrickson Type V Hyperlipoproteinemia; Hyperlipoproteinemia, Fredrickson Type V

Hyperlipoproteinemia Type V is characterized by increased plasma levels of chylomicrons, VLDL, pre-β-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with β-lipoproteins normal.

Drugs used to treat Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL

Name Drug Class Updated
Niavasc Drugs 15-Aug-2023
Fenofibric acid/fenofibrate (monograph) Drugs 14-Aug-2023
Antara Fibric acid derivatives 05-Aug-2023
Lipofen Fibric acid derivatives 05-Aug-2023
Slo-niacin Miscellaneous antihyperlipidemic agents 05-Aug-2023
Triglide Fibric acid derivatives 14-Jul-2023
Tricor Fibric acid derivatives 14-Jul-2023
Niacor Miscellaneous antihyperlipidemic agents 13-Jul-2023
Niacin sr Miscellaneous antihyperlipidemic agents 13-Jul-2023
Lopid Fibric acid derivatives 13-Jul-2023
Fenoglide Fibric acid derivatives 13-Jul-2023
Endur-acin Miscellaneous antihyperlipidemic agents 13-Jul-2023
Niaspan er Miscellaneous antihyperlipidemic agents 11-Jul-2023
Gemfibrozil Fibric acid derivatives 10-Jul-2023
Fenofibrate Fibric acid derivatives 10-Jul-2023
Share this Article
Latest News
Related Drugs